Continuous Infusion of the CXCR4 Antagonist Plerixafor for WHIM Syndrome.
Saved in:
| Title: | Continuous Infusion of the CXCR4 Antagonist Plerixafor for WHIM Syndrome. |
|---|---|
| Authors: | McDermott DH; Laboratory of Molecular Immunology, National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH), Bethesda, MD, USA., Majumdar S; Laboratory of Molecular Immunology, National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH), Bethesda, MD, USA., Velez D; Laboratory of Molecular Immunology, National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH), Bethesda, MD, USA., Cho E; Laboratory of Molecular Immunology, National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH), Bethesda, MD, USA., Li Z; Laboratory of Molecular Immunology, National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH), Bethesda, MD, USA., Gao JL; Laboratory of Molecular Immunology, National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH), Bethesda, MD, USA., Grieco MC; Biostatics Research Branch, Division of Clinical Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.; Axle Informatics, Bethesda, MD, USA., Lawrence MG; Division of Asthma, Allergy and Immunology, University of Virginia School of Medicine, Charlottesville, VA, USA., Silva SL; Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal.; Serviço de Imunoalergologia, Unidade Local de Saúde de Santa Maria, Lisbon, Portugal.; Gulbenkian Institute for Molecular Medicine, Lisbon, Portugal., Castelo-Soccio LA; Office of the Director, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD, USA., Follmann D; Biostatics Research Branch, Division of Clinical Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA., Murphy PM; Laboratory of Molecular Immunology, National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH), Bethesda, MD, USA. pmm@nih.gov. |
| Source: | Journal of clinical immunology [J Clin Immunol] 2026 Mar 29; Vol. 46 (1). Date of Electronic Publication: 2026 Mar 29. |
| Publication Type: | Journal Article; Clinical Trial, Phase II; Clinical Trial, Phase I |
| Journal Info: | Publisher: Springer Country of Publication: Netherlands NLM ID: 8102137 Publication Model: Electronic Cited Medium: Internet ISSN: 1573-2592 (Electronic) Linking ISSN: 02719142 NLM ISO Abbreviation: J Clin Immunol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41904735 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Continuous Infusion of the CXCR4 Antagonist Plerixafor for WHIM Syndrome. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22McDermott+DH%22">McDermott DH</searchLink>; Laboratory of Molecular Immunology, National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH), Bethesda, MD, USA.<br /><searchLink fieldCode="AU" term="%22Majumdar+S%22">Majumdar S</searchLink>; Laboratory of Molecular Immunology, National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH), Bethesda, MD, USA.<br /><searchLink fieldCode="AU" term="%22Velez+D%22">Velez D</searchLink>; Laboratory of Molecular Immunology, National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH), Bethesda, MD, USA.<br /><searchLink fieldCode="AU" term="%22Cho+E%22">Cho E</searchLink>; Laboratory of Molecular Immunology, National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH), Bethesda, MD, USA.<br /><searchLink fieldCode="AU" term="%22Li+Z%22">Li Z</searchLink>; Laboratory of Molecular Immunology, National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH), Bethesda, MD, USA.<br /><searchLink fieldCode="AU" term="%22Gao+JL%22">Gao JL</searchLink>; Laboratory of Molecular Immunology, National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH), Bethesda, MD, USA.<br /><searchLink fieldCode="AU" term="%22Grieco+MC%22">Grieco MC</searchLink>; Biostatics Research Branch, Division of Clinical Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.; Axle Informatics, Bethesda, MD, USA.<br /><searchLink fieldCode="AU" term="%22Lawrence+MG%22">Lawrence MG</searchLink>; Division of Asthma, Allergy and Immunology, University of Virginia School of Medicine, Charlottesville, VA, USA.<br /><searchLink fieldCode="AU" term="%22Silva+SL%22">Silva SL</searchLink>; Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal.; Serviço de Imunoalergologia, Unidade Local de Saúde de Santa Maria, Lisbon, Portugal.; Gulbenkian Institute for Molecular Medicine, Lisbon, Portugal.<br /><searchLink fieldCode="AU" term="%22Castelo-Soccio+LA%22">Castelo-Soccio LA</searchLink>; Office of the Director, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD, USA.<br /><searchLink fieldCode="AU" term="%22Follmann+D%22">Follmann D</searchLink>; Biostatics Research Branch, Division of Clinical Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.<br /><searchLink fieldCode="AU" term="%22Murphy+PM%22">Murphy PM</searchLink>; Laboratory of Molecular Immunology, National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH), Bethesda, MD, USA. pmm@nih.gov. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%228102137%22">Journal of clinical immunology</searchLink> [J Clin Immunol] 2026 Mar 29; Vol. 46 (1). <i>Date of Electronic Publication: </i>2026 Mar 29. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Clinical Trial, Phase II; Clinical Trial, Phase I – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer%22">Springer </searchLink><i>Country of Publication: </i>Netherlands <i>NLM ID: </i>8102137 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1573-2592 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2202719142%22">02719142 </searchLink><i>NLM ISO Abbreviation: </i>J Clin Immunol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41904735 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1007/s10875-026-02010-4 Languages: – Code: eng Text: English Titles: – TitleFull: Continuous Infusion of the CXCR4 Antagonist Plerixafor for WHIM Syndrome. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: McDermott DH – PersonEntity: Name: NameFull: Majumdar S – PersonEntity: Name: NameFull: Velez D – PersonEntity: Name: NameFull: Cho E – PersonEntity: Name: NameFull: Li Z – PersonEntity: Name: NameFull: Gao JL – PersonEntity: Name: NameFull: Grieco MC – PersonEntity: Name: NameFull: Lawrence MG – PersonEntity: Name: NameFull: Silva SL – PersonEntity: Name: NameFull: Castelo-Soccio LA – PersonEntity: Name: NameFull: Follmann D – PersonEntity: Name: NameFull: Murphy PM IsPartOfRelationships: – BibEntity: Dates: – D: 29 M: 03 Text: 2026 Mar 29 Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1573-2592 Numbering: – Type: volume Value: 46 – Type: issue Value: 1 Titles: – TitleFull: Journal of clinical immunology Type: main |
| ResultId | 1 |